Scott Knackstedt is a seasoned professional with extensive experience in commercialization and strategic consulting within the health and biotechnology sectors. As a Senior Commercialization Officer at PATH since February 2018, Scott drives innovation and technology access for improved health in low-resource settings. In addition, Scott serves as the Board President of the Global Snakebite Initiative USA Foundation, focusing on enhancing treatment quality and community engagement programs. Previous roles include Strategy Consultant at Cyrus Biotechnology, Consultant at 2A, and Summer Associate at Global Partnerships, among others. Scott holds an MBA from the UW Foster School of Business and advanced degrees from the University of Cambridge, Diplomatische Akademie Wien, and the University of Portland.
This person is not in the org chart
This person is not in any teams
This person is not in any offices